Mereo BioPharma Group
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Cavendish Place Floor 4, London, Great...Phone Number
+44 3330237300Website
www.mereobiopharma.comRevenue
-Stock Symbol
MREOIndustry
About Mereo BioPharma Group
Mereo is a biopharmaceutical company focused on the development and commercialisation of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have already received significant investment from pharmaceutical companies and that have substantial preclinical, clinical and manufacturing data packages. In December 2018, Mereo announced the proposed combination of Mereo and OncoMed Pharmaceuticals, with the transaction expected to close in the second quarter of 2019. Each of Mereo's four product candidates has previously generated positive clinical data for Mereo's target indication or in a related indication.Explore more
Mereo BioPharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mereo BioPharma Group
Compare insights from companies similar to Mereo BioPharma Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mereo BioPharma Group Tech Stack
A closer look at the technologies used by Mereo BioPharma Group
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mereo BioPharma Group
Sign Up For FreeTo access detailed company insights
Mereo is a biopharmaceutical company focused on the development and commercialisation of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have already received significant investment from pharmaceutical companies and that have substantial preclin... Read More
